Durable Complete Response to Pembrolizumab in Esophageal Squamous Cell Carcinoma With Divergent Microsatellite Status: A Case Report

Microsatellite instability-high (MSI-H) is widely believed to be a biomarker for immune checkpoint inhibitors (ICIs) such as pembrolizumab in solid tumors. However, due to the low prevalence of MSI-H in most cancers, it tends to be insufficient to identify whether patients should receive ICIs accord...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Tian, Zhang, Lei, Chen, Can, Zhao, Xiang, Liu, Xiaoqing, Ran, Fengwei, Yong, Tingting, Yang, Ying, Zhang, Henghui, Zhang, Yanling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640956/
https://www.ncbi.nlm.nih.gov/pubmed/34868995
http://dx.doi.org/10.3389/fonc.2021.767957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640956/
https://www.ncbi.nlm.nih.gov/pubmed/34868995
http://dx.doi.org/10.3389/fonc.2021.767957

Ejemplares similares